

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.18959052 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.04738731 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.01255535 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.93977937 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.93977937 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.73981497 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49600766 |
| 8 | negative regulation of phagocytosis (GO:0050765) | 5.32634305 |
| 9 | regulation of activation of Janus kinase activity (GO:0010533) | 5.30273593 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51418621 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.43648903 |
| 12 | regulation of mast cell degranulation (GO:0043304) | 4.29079034 |
| 13 | detection of bacterium (GO:0016045) | 4.13406722 |
| 14 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.06887411 |
| 15 | detection of other organism (GO:0098543) | 4.03923128 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 3.97229365 |
| 17 | leukocyte aggregation (GO:0070486) | 3.95652757 |
| 18 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.94044778 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.89419974 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84745144 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84745144 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84745144 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.84745144 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84745144 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.84745144 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84397954 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.78417457 |
| 28 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.72972394 |
| 29 | response to interleukin-15 (GO:0070672) | 3.71788452 |
| 30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.67267166 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.64359033 |
| 32 | regulation of leukocyte degranulation (GO:0043300) | 3.57725581 |
| 33 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.52448955 |
| 34 | tolerance induction (GO:0002507) | 3.52222349 |
| 35 | response to type I interferon (GO:0034340) | 3.50179879 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46691105 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.45942448 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.45942448 |
| 39 | neutrophil activation (GO:0042119) | 3.37144196 |
| 40 | granulocyte activation (GO:0036230) | 3.36025852 |
| 41 | axonemal dynein complex assembly (GO:0070286) | 3.35388632 |
| 42 | regulation of mast cell activation (GO:0033003) | 3.34486732 |
| 43 | respiratory burst (GO:0045730) | 3.33434256 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 3.30908099 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24083916 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.23774556 |
| 47 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.23263204 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.21551507 |
| 49 | regulation of cellular extravasation (GO:0002691) | 3.19963517 |
| 50 | negative regulation of mast cell activation (GO:0033004) | 3.15075262 |
| 51 | regulation of tolerance induction (GO:0002643) | 3.13919541 |
| 52 | positive regulation of interleukin-17 production (GO:0032740) | 3.12054993 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.11823649 |
| 54 | regulation of memory T cell differentiation (GO:0043380) | 3.11349048 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07017396 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.06332185 |
| 57 | B cell mediated immunity (GO:0019724) | 3.03596144 |
| 58 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.01693021 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.01250639 |
| 60 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.00459976 |
| 61 | negative regulation of B cell proliferation (GO:0030889) | 2.99846245 |
| 62 | negative T cell selection (GO:0043383) | 2.99351912 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 2.98191943 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 2.97895787 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 2.96898938 |
| 66 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.94540706 |
| 67 | regulation of B cell differentiation (GO:0045577) | 2.93772851 |
| 68 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91620109 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91320110 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90468452 |
| 71 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90468452 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84480323 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83572461 |
| 74 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.81133268 |
| 75 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.81074122 |
| 76 | negative regulation of innate immune response (GO:0045824) | 2.79966793 |
| 77 | response to peptidoglycan (GO:0032494) | 2.78379062 |
| 78 | leukocyte degranulation (GO:0043299) | 2.78074449 |
| 79 | positive regulation of tolerance induction (GO:0002645) | 2.77586429 |
| 80 | cytidine metabolic process (GO:0046087) | 2.75849855 |
| 81 | cytidine catabolic process (GO:0006216) | 2.75849855 |
| 82 | cytidine deamination (GO:0009972) | 2.75849855 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 2.74561836 |
| 84 | response to host immune response (GO:0052572) | 2.74092289 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74092289 |
| 86 | motile cilium assembly (GO:0044458) | 2.73107674 |
| 87 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71182048 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69321968 |
| 89 | regulation of cell killing (GO:0031341) | 2.67195258 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.63893834 |
| 91 | positive regulation of cell killing (GO:0031343) | 2.63213207 |
| 92 | regulation of T cell mediated immunity (GO:0002709) | 2.62856830 |
| 93 | cellular extravasation (GO:0045123) | 2.61904617 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.61182836 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60831827 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57861079 |
| 97 | regulation of leukocyte mediated immunity (GO:0002703) | 2.57714573 |
| 98 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.56729433 |
| 99 | thymic T cell selection (GO:0045061) | 2.53981098 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53122695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.39735282 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.40398252 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.16128261 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18871453 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84557265 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69533483 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48610370 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40840331 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40299794 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35915107 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33999090 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33022215 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28645964 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.23553757 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20140575 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19908299 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.06732441 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.06495740 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05290883 |
| 20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01284312 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.00508526 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00061385 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99196735 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98593292 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93392505 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92437670 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91761279 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.85339437 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82834795 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73557914 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69578222 |
| 32 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69396828 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.68886066 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67754419 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62712873 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62564981 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61968238 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61624635 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61074737 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60080997 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53250524 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50631114 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.50443361 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48937521 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48615805 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48336229 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.48334095 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43207534 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39690233 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39506081 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38762725 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37418576 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36785814 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35095783 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34879362 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32635011 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31689237 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30433559 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26273561 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25909104 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25788137 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.19814137 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19542668 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17339755 |
| 65 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16932773 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16572169 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16441997 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16104072 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15466965 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14640475 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13962176 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13813762 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13480475 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13061900 |
| 75 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13030304 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12712254 |
| 77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12686858 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12296888 |
| 79 | P300_27268052_Chip-Seq_Bcells_Human | 1.10827640 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10555235 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09881771 |
| 82 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07522058 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07413075 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06792982 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05587864 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04697444 |
| 87 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.04257000 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04220696 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03963961 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03886405 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02448346 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01773904 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01747055 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01575721 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01357046 |
| 96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99095212 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99071980 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98975682 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98805351 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97765677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.15387420 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.46629442 |
| 3 | MP0005671_abnormal_response_to | 3.35767303 |
| 4 | MP0003436_decreased_susceptibility_to | 3.31571102 |
| 5 | MP0003303_peritoneal_inflammation | 3.30999253 |
| 6 | MP0010155_abnormal_intestine_physiology | 2.86712425 |
| 7 | MP0005025_abnormal_response_to | 2.80369676 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.79377284 |
| 9 | MP0009785_altered_susceptibility_to | 2.72095055 |
| 10 | MP0003866_abnormal_defecation | 2.69401658 |
| 11 | MP0001800_abnormal_humoral_immune | 2.68718503 |
| 12 | MP0006082_CNS_inflammation | 2.66233024 |
| 13 | MP0005387_immune_system_phenotype | 2.61815168 |
| 14 | MP0001790_abnormal_immune_system | 2.61815168 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.57103670 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.52394090 |
| 17 | MP0002419_abnormal_innate_immunity | 2.48683338 |
| 18 | MP0002723_abnormal_immune_serum | 2.35089710 |
| 19 | MP0001819_abnormal_immune_cell | 2.27524947 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.27146221 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.25567232 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.22901254 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.21481221 |
| 24 | MP0000685_abnormal_immune_system | 2.18210478 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.15949305 |
| 26 | MP0002132_abnormal_respiratory_system | 2.07428734 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.90859254 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.83250614 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.80928157 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.78761934 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.78020305 |
| 32 | MP0002405_respiratory_system_inflammati | 1.76267330 |
| 33 | MP0000490_abnormal_crypts_of | 1.74490559 |
| 34 | MP0000716_abnormal_immune_system | 1.65600742 |
| 35 | MP0002398_abnormal_bone_marrow | 1.64451161 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.62170952 |
| 37 | MP0001873_stomach_inflammation | 1.60730975 |
| 38 | MP0004947_skin_inflammation | 1.52449656 |
| 39 | MP0001663_abnormal_digestive_system | 1.50689311 |
| 40 | MP0001765_abnormal_ion_homeostasis | 1.48380332 |
| 41 | MP0008469_abnormal_protein_level | 1.44526434 |
| 42 | MP0005166_decreased_susceptibility_to | 1.43502757 |
| 43 | MP0005310_abnormal_salivary_gland | 1.39766229 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.39563819 |
| 45 | MP0005360_urolithiasis | 1.39409621 |
| 46 | MP0004043_abnormal_pH_regulation | 1.38807413 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.37945782 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.35989892 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.35098948 |
| 50 | MP0002722_abnormal_immune_system | 1.34130479 |
| 51 | MP0002429_abnormal_blood_cell | 1.34046719 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.33858538 |
| 53 | MP0003878_abnormal_ear_physiology | 1.33858538 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.33716662 |
| 55 | MP0005451_abnormal_body_composition | 1.32190716 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.29712430 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.28366553 |
| 58 | MP0000858_altered_metastatic_potential | 1.20465942 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.15680571 |
| 60 | MP0001664_abnormal_digestion | 1.15482373 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.15294083 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.10854212 |
| 63 | MP0009764_decreased_sensitivity_to | 1.10566081 |
| 64 | MP0003075_altered_response_to | 1.09639566 |
| 65 | MP0009840_abnormal_foam_cell | 1.07468484 |
| 66 | MP0000678_abnormal_parathyroid_gland | 1.07199981 |
| 67 | MP0005381_digestive/alimentary_phenotyp | 1.03772637 |
| 68 | MP0009278_abnormal_bone_marrow | 1.00171219 |
| 69 | MP0001851_eye_inflammation | 0.98873846 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96813950 |
| 71 | MP0000477_abnormal_intestine_morphology | 0.96362185 |
| 72 | MP0002396_abnormal_hematopoietic_system | 0.95655031 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.95287547 |
| 74 | MP0001545_abnormal_hematopoietic_system | 0.93222589 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.93222589 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.92675277 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.91394225 |
| 78 | MP0002653_abnormal_ependyma_morphology | 0.90426825 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.86676742 |
| 80 | MP0001666_abnormal_nutrient_absorption | 0.86467646 |
| 81 | MP0000343_altered_response_to | 0.85726199 |
| 82 | MP0003045_fibrosis | 0.85620414 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.85563131 |
| 84 | MP0002006_tumorigenesis | 0.85511471 |
| 85 | MP0004381_abnormal_hair_follicle | 0.84404123 |
| 86 | MP0005365_abnormal_bile_salt | 0.84361660 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.84207468 |
| 88 | MP0009763_increased_sensitivity_to | 0.83836259 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.76159971 |
| 90 | MP0008004_abnormal_stomach_pH | 0.75680516 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 0.73957748 |
| 92 | MP0005164_abnormal_response_to | 0.73767675 |
| 93 | MP0003448_altered_tumor_morphology | 0.71819235 |
| 94 | MP0002933_joint_inflammation | 0.70537876 |
| 95 | MP0000249_abnormal_blood_vessel | 0.68798312 |
| 96 | MP0000609_abnormal_liver_physiology | 0.66802422 |
| 97 | MP0003828_pulmonary_edema | 0.65485677 |
| 98 | MP0005390_skeleton_phenotype | 0.64800816 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.62946343 |
| 100 | MP0000604_amyloidosis | 0.62418757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.92643079 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.34321219 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 5.34321219 |
| 4 | Myositis (HP:0100614) | 5.16851156 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.55929241 |
| 6 | Orchitis (HP:0100796) | 4.55855547 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.52082308 |
| 8 | Optic neuritis (HP:0100653) | 4.38747760 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.38747760 |
| 10 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.38573841 |
| 11 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.38573841 |
| 12 | Nasal polyposis (HP:0100582) | 4.38102469 |
| 13 | Abnormal ciliary motility (HP:0012262) | 4.24976673 |
| 14 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.99631722 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.98979877 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.97956740 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.91526640 |
| 18 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.84690413 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 3.64436774 |
| 20 | Encephalitis (HP:0002383) | 3.63721905 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.58932768 |
| 22 | Meningitis (HP:0001287) | 3.45267090 |
| 23 | Increased IgE level (HP:0003212) | 3.45106621 |
| 24 | Obstructive lung disease (HP:0006536) | 3.40731974 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.40731974 |
| 26 | Chronic otitis media (HP:0000389) | 3.30669253 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29261251 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.23689401 |
| 29 | Bronchiectasis (HP:0002110) | 3.23428451 |
| 30 | Malnutrition (HP:0004395) | 3.21453356 |
| 31 | Recurrent sinusitis (HP:0011108) | 3.20737398 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18309651 |
| 33 | Pustule (HP:0200039) | 3.16080955 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.09854729 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.06479250 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.00974670 |
| 37 | Rhinitis (HP:0012384) | 2.99592814 |
| 38 | Vasculitis (HP:0002633) | 2.99222904 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.98275056 |
| 40 | Petechiae (HP:0000967) | 2.90020971 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.86635610 |
| 42 | Chronic bronchitis (HP:0004469) | 2.85732064 |
| 43 | Recurrent skin infections (HP:0001581) | 2.85383698 |
| 44 | Gingivitis (HP:0000230) | 2.78785779 |
| 45 | Urticaria (HP:0001025) | 2.77048240 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.67525499 |
| 47 | T lymphocytopenia (HP:0005403) | 2.67484659 |
| 48 | Bronchitis (HP:0012387) | 2.67143517 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.66346146 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.59515954 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.57515560 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.57278181 |
| 53 | Pulmonary embolism (HP:0002204) | 2.55449089 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.54363891 |
| 55 | Stomatitis (HP:0010280) | 2.49549885 |
| 56 | Hemoptysis (HP:0002105) | 2.49147523 |
| 57 | Chronic sinusitis (HP:0011109) | 2.48701323 |
| 58 | Abnormality of renin-angiotensin system (HP:0000847) | 2.43898040 |
| 59 | Chronic diarrhea (HP:0002028) | 2.40910563 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.40156383 |
| 61 | Abnormality of T cells (HP:0002843) | 2.34974168 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31391898 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31391898 |
| 64 | Anorexia (HP:0002039) | 2.30920350 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.29124599 |
| 66 | Granulocytopenia (HP:0001913) | 2.25717727 |
| 67 | Epistaxis (HP:0000421) | 2.22547281 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.22350920 |
| 69 | Cellulitis (HP:0100658) | 2.20695730 |
| 70 | Premature loss of primary teeth (HP:0006323) | 2.18830170 |
| 71 | Chest pain (HP:0100749) | 2.18453083 |
| 72 | Recurrent viral infections (HP:0004429) | 2.17530942 |
| 73 | Arterial thrombosis (HP:0004420) | 2.17146543 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.16781124 |
| 75 | Increased IgM level (HP:0003496) | 2.16044088 |
| 76 | Gingival bleeding (HP:0000225) | 2.14907565 |
| 77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10891952 |
| 78 | Purpura (HP:0000979) | 2.10513379 |
| 79 | Leukocytosis (HP:0001974) | 2.08187075 |
| 80 | Hypochromic anemia (HP:0001931) | 2.07877087 |
| 81 | Gangrene (HP:0100758) | 2.03746002 |
| 82 | Alkalosis (HP:0001948) | 2.03418032 |
| 83 | Recurrent otitis media (HP:0000403) | 2.03233281 |
| 84 | Recurrent pneumonia (HP:0006532) | 2.03116677 |
| 85 | Eosinophilia (HP:0001880) | 2.02368312 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 1.97991701 |
| 87 | Glomerulopathy (HP:0100820) | 1.94388924 |
| 88 | Acne (HP:0001061) | 1.93864591 |
| 89 | Gastrointestinal dysmotility (HP:0002579) | 1.93782726 |
| 90 | Hemorrhage of the eye (HP:0011885) | 1.92245843 |
| 91 | Abnormality of eosinophils (HP:0001879) | 1.89985570 |
| 92 | Severe visual impairment (HP:0001141) | 1.88869038 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.85948689 |
| 94 | Microcytic anemia (HP:0001935) | 1.85760303 |
| 95 | Abnormality of chloride homeostasis (HP:0011422) | 1.85307583 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82724595 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 1.80768970 |
| 98 | Osteomyelitis (HP:0002754) | 1.80671657 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 1.78852350 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.78592259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.46844618 |
| 2 | RIPK4 | 4.41445510 |
| 3 | IRAK4 | 2.98037810 |
| 4 | TXK | 2.91214870 |
| 5 | ERN1 | 2.76129597 |
| 6 | ZAP70 | 2.55164906 |
| 7 | EPHB1 | 2.54892407 |
| 8 | CSK | 2.45727314 |
| 9 | BLK | 2.40305997 |
| 10 | GRK6 | 2.16827566 |
| 11 | TNK2 | 1.93808240 |
| 12 | TYK2 | 1.92378777 |
| 13 | BTK | 1.87099092 |
| 14 | TESK2 | 1.84220657 |
| 15 | TBK1 | 1.83770026 |
| 16 | MAP2K3 | 1.79169276 |
| 17 | FES | 1.77229347 |
| 18 | SYK | 1.69317280 |
| 19 | ACVR1B | 1.68876994 |
| 20 | CDC42BPA | 1.61637394 |
| 21 | JAK3 | 1.58355307 |
| 22 | LIMK1 | 1.55069168 |
| 23 | MAP3K11 | 1.50078739 |
| 24 | TRIB3 | 1.47757546 |
| 25 | LYN | 1.42115365 |
| 26 | MATK | 1.41975641 |
| 27 | KIT | 1.40470305 |
| 28 | PTK6 | 1.40394955 |
| 29 | EPHA2 | 1.38730545 |
| 30 | JAK1 | 1.38719518 |
| 31 | HCK | 1.37829694 |
| 32 | PRPF4B | 1.37019505 |
| 33 | MAP3K3 | 1.35941491 |
| 34 | IKBKE | 1.35032598 |
| 35 | MST4 | 1.31542627 |
| 36 | ITK | 1.26970061 |
| 37 | LCK | 1.22292274 |
| 38 | MAP3K14 | 1.22015640 |
| 39 | CDK19 | 1.18799329 |
| 40 | MAPK15 | 1.17931534 |
| 41 | MAP3K1 | 1.16753515 |
| 42 | TAOK1 | 1.13892420 |
| 43 | KDR | 1.12575590 |
| 44 | EPHA3 | 1.12142433 |
| 45 | TAOK3 | 1.05836084 |
| 46 | PRKG2 | 1.05268368 |
| 47 | TEC | 1.04408166 |
| 48 | SMG1 | 1.03913725 |
| 49 | FGR | 1.02637640 |
| 50 | PRKD2 | 0.98407400 |
| 51 | PRKCQ | 0.98137879 |
| 52 | MST1R | 0.95870837 |
| 53 | BMPR2 | 0.93556883 |
| 54 | SIK3 | 0.91920283 |
| 55 | PDK1 | 0.89676735 |
| 56 | IRAK1 | 0.88805422 |
| 57 | JAK2 | 0.87518875 |
| 58 | MAP3K2 | 0.87099434 |
| 59 | PDPK1 | 0.86020302 |
| 60 | IKBKB | 0.85713941 |
| 61 | CSF1R | 0.84416248 |
| 62 | PIK3CA | 0.80594744 |
| 63 | MAP2K6 | 0.73724540 |
| 64 | FGFR3 | 0.71639174 |
| 65 | MAP2K2 | 0.71590620 |
| 66 | STK16 | 0.70622011 |
| 67 | MARK3 | 0.68556746 |
| 68 | PTK2B | 0.68109779 |
| 69 | TESK1 | 0.67223071 |
| 70 | FGFR4 | 0.67156322 |
| 71 | MAPK11 | 0.62060116 |
| 72 | FYN | 0.60779771 |
| 73 | MAPKAPK2 | 0.60503704 |
| 74 | ADRBK2 | 0.59431556 |
| 75 | RIPK1 | 0.58223583 |
| 76 | MARK2 | 0.57952717 |
| 77 | MAP3K13 | 0.53538151 |
| 78 | STK10 | 0.51886381 |
| 79 | KSR2 | 0.51085389 |
| 80 | MAP3K7 | 0.50338017 |
| 81 | MAP3K6 | 0.49350800 |
| 82 | OXSR1 | 0.45283444 |
| 83 | PIM1 | 0.45062212 |
| 84 | MAPK7 | 0.43946186 |
| 85 | LRRK2 | 0.43031194 |
| 86 | MELK | 0.42878000 |
| 87 | CAMKK2 | 0.42803026 |
| 88 | TLK1 | 0.41876472 |
| 89 | PKN2 | 0.41096997 |
| 90 | HIPK2 | 0.40652338 |
| 91 | STK24 | 0.40086490 |
| 92 | PRKCD | 0.39977559 |
| 93 | CLK1 | 0.39959189 |
| 94 | CAMKK1 | 0.36258242 |
| 95 | RET | 0.35936467 |
| 96 | NLK | 0.35865555 |
| 97 | MAPK12 | 0.35855041 |
| 98 | DYRK1B | 0.34042637 |
| 99 | SIK2 | 0.33802648 |
| 100 | CDK4 | 0.30156837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.31163852 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.93440391 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75462473 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64417653 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.46678759 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33330272 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.31642504 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22652467 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19679680 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19262137 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.17398932 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13057308 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.00571682 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94310957 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.88452035 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71228350 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68261191 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65192583 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.63376779 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56602903 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51358681 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40836033 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40277929 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36874029 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33971703 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33536431 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33231630 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31760083 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25828893 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.23411314 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22876138 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20846726 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20171859 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18785873 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18218615 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16318731 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15573077 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.15294401 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14317893 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.13332863 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13194788 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10682586 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.09597396 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04822645 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.04043652 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99426353 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98208676 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96817107 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96338357 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93855610 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86570648 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86402438 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.86070790 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.84849113 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84021864 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82826654 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82352452 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81709002 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80073452 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.76982110 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76017617 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75962248 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.75695878 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74591632 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74333658 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73232662 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72655146 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72030742 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71691338 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.71658204 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67476999 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.66004907 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64733300 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64574336 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63510066 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.63376215 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59981833 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59461041 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56437075 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56433138 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.52556488 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51478762 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47467986 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46847033 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46498659 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44829740 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44772136 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44117024 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43419162 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43186545 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.42751782 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41739700 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.39358338 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39010589 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38219677 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.37868519 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37681093 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37162657 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36304001 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35185150 |

